THE CORPORATE REPUTATION OF PHARMA THE PATIENT PERSPECTIVE IN 2015 (LATIN AMERICA EDITION)

Transcription

1 THE CORPORATE REPUTATION OF PHARMA THE PATIENT PERSPECTIVE IN 2015 (LATIN AMERICA EDITION) Feedback from 58 Latin-American patient groups PUBLISHED JUNE 2016

2 Que las Compañias Farmacéuticas tengan relación directa o indirectamente con mi organizacion, ayudando a la ONG para ayudar a los pacientes de poco o sin recursos. National Argentina-based patient group specialising in hepatitis and HIV/AIDS in 2016, patientview is publishing 20 corporate reputation of pharma reports, analysing the results from the 1,075 patient groups responding to the 2015 survey. specialty reports: cancer I circulatory conditions I diabetes I hiv/aids I hepatitis I neurological conditions I mental health I respiratory conditions I skin conditions I rare diseases (10 reports) geographic-region reports (in addition to this current latam report): europe-wide I eastern europe I germany I global I italy I nordic I spain I uk I usa (10 reports)

3 CONTENTS ABOUT THIS REPORT Page 1 WHAT DID PATIENT GROUPS IN LATIN AMERICA SAY ABOUT PHARMA IN 2015? Summary of the industry-wide findings in Latin America Page 3 SOME POINTS ABOUT THE LATIN-AMERICAN CORPORATE RANKINGS Page 6 WHAT CAN PHARMA COMPANIES DO TO IMPROVE THEIR CORPORATE REPUTATION? Page 7 A FEW COMMENTS FROM PATIENT GROUPS IN LATIN AMERICA, 2015 Page 8 CASE STUDY: PATIENT-GROUP RELATIONS AND PATIENT CENTRICITY AT AbbVie Mexico Page 9 METHODOLOGY OF THE PATIENT-GROUP SURVEY Page 11 QUESTIONNAIRE FOR PHARMA COMPANIES 2015 Page 12 APPENDIX 1: Data on how patient groups in Latin America see the pharmaceutical industry in 2015 APPENDIX 2: Rankings of the 13 pharma companies for each of the 6 indicators of corporate reputation, as perceived by patient groups in Latin America in 2015 APPENDIX 3: Profiles of the 13 companies Page 13 Page 18 Page 27 APPENDIX 4: Profiles of the 58 respondent patient groups Page 42

4 LIST OF TABLES AND CHARTS BASED ON THE VIEWS OF PATIENT GROUPS IN LATIN AMERICA Percentage of patient groups in Latin America claiming familiarity with the company Page 2 Percentage of patient groups in Latin America claiming familiarity, and which also worked with the company Page 2 % of patient groups (by geographic region) stating that pharma is Excellent or Good at BEING INNOVATIVE Page 4 % of patient groups (by geographic region) stating that pharma is Excellent or Good at PROVIDING SERVICES TO PATIENTS OUTSIDE ITS BUSINESS REMIT Page 4 % of patient groups (by geographic region) stating that pharma is Excellent or Good at BEING TRANSPARENT IN ALL CORPORATE ACTIVITIES Page 4 Average scores for each of the six indicators of corporate reputation in 2015, according to patient groups based in Latin America, v. worldwide Page 6 The corporate reputation of pharma companies in 2015, according to patient groups based in Latin America, v. worldwide If a pharma company wishes to improve its corporate reputation with patients and patient groups, which single strategy from the list below do you think would be MOST IMPORTANT for the company to follow? Please select only ONE option How do you think your organisation s members (or the people you represent) would rate the corporate reputation of the following healthcare sectors in 2015? Page 6 Page 7 Page 14 What do you think has happened to the corporate reputation of the pharma industry over the past five years? Page 15 How good or bad do you think the pharma industry is in 2015 at carrying out the following activities (all of which influence their corporate standing with patients and patient groups in Latin America)? Pages Companies with the most effective patient-centred strategy (rankings of 13 companies, 2015) Page 19 Companies providing the best high-quality patient information (rankings of 13 companies, 2015) Page 20 Companies with the best record on patient safety (rankings of 13 companies, 2015) Page 21 Companies with the most-useful high-quality products (rankings of 13 companies, 2015) Page 22 Companies with the best record of transparency (rankings of 13 companies, 2015) Page 23 Companies with the best record on integrity (rankings of 13 companies, 2015) Page 24 Rankings of the 13 pharmaceutical companies in 2015, ALPHABETIC ORDER Page 25 Rankings of the 13 pharmaceutical companies in 2015, HIGHEST TO LOWEST Page 26 Profile of 2015 s 58 respondent patient groups based in Latin America by therapy area Page 43 Profile of 2015 s 58 respondent patient groups based in Latin America by country Page 43 Geographic remit of 2015 s 58 respondent Latin-American patient groups Page 44

5 LIST OF TABLES AND CHARTS CONTINUED AbbVie page 45 AstraZeneca page 51 Bayer page 53 Boehringer Ingelheim page 55 B-MS page 56 Eli Lilly page 60 GSK page 65 Janssen page 68 Merck & Co (US) page 72 Novartis page 75 Pfizer page 79 Roche page 80 Sanofi page 82 profiles of the 13 companies, according to the patient groups in latin america familiar with these companies, or have worked with them Each profile contains... company background information Annual revenue (latest-available year), comprising amount in currency, as quoted by the profiled company itself. = increase in revenue over the previous year or = decrease in revenue. The profiled company s main treatment subject areas (and areas of R&D). A mission statement from the profiled company. how the company has performed at six indicators of corporate reputation The profiled company s performance at the six indicators of corporate reputation in 2015, according to the patient groups in Latin America familiar with the company. The profiled company s performance at the six indicators of corporate reputation, according to the patient groups in Latin America that have worked with the company. How the profiled company performed in Latin America for different therapy areas, compared with the company s averages in Latin America across all therapy areas in How the profiled company performed in Latin America for different countries/regions, compared with the company s averages in Latin America in how the company ranks for corporate reputation compared with other companies The profiled company s rankings in Latin America in 2015 for the six indicators of corporate reputation, compared with 12 other companies The profiled company s rankings worldwide in 2015 for the six indicators of corporate reputation, compared with 47 other companies profile of the patient groups familiar with the company Other companies that partner with a significant number of the profiled company s partner patient groups. The therapy areas and countries of the patient groups familiar with the profiled company. Janssen Pharmaceutical Companies of Johnson & Johnson

6 Contact details PatientView Registered office: One Fleet Place, London, EC4M 7WS, UK Tel: +44-(0) Registered in England, number: Data protection registration number: Z VAT registration number: GB Copyright 2016 PatientView Ltd. All rights reserved. This booklet is the property of PatientView, and no part may be reproduced without permission, or passed on to any third party without the permission of PatientView.